JOURNAL ARTICLE
Molecular Dynamic Simulations of Dual Inhibitors for AChE and BChE; Theoretical and Experimental Approaches.
Published In: Journal of Computational Biophysics & Chemistry, 2024, v. 23, n. 8. P. 1011 1 of 3
Database: Academic Search Ultimate 2 of 3
Authored By: Raza, Muhammad Asam; Arif, Maimoona; Farwa, Umme; Sandhu, Zeshan Ali; Ashraf, Adnan; Bahyoune, Nouhaila; Nashre-ul-Islam, Swah Mohd.; Almutairi, Tahani Mazyad; Bouissane, Latifa 3 of 3
Abstract
The aim of the study is to design and synthesize thiazolidinone derivatives having therapeutic potential using PABA as a core component. The characterization of thiazolidinones MS1–MS6 was carried out using different spectroscopic techniques before being subjected to DFT studies to calculate various parameters such as HOMO/LUMO energy gaps and global chemical properties. Thiazolidinones MS1–MS6 were screened to evaluate their in vitro enzyme inhibition potential. In addition to experimental work, theoretical approaches were used as supporting components to design the enzyme inhibitors. In-silico ADMET and docking studies were performed to check the therapeutic properties of thiazolidinone derivatives. The enzyme inhibition potential predicted that MS1–MS6 have potential to inhibit AChE and BChE. The highest activity was depicted by MS4 with a percentage inhibition of 81.7 ± 1.1% against AChE. The molecular dynamic simulation was run for MS4 showing a similar activity on enzyme compared to the standard inhibitor. Both experimental and theoretical assessments suggested the therapeutic importance of the thiazolidinone derivatives MS1–MS6. In-depth studies are ongoing to complete therapeutic probing in terms of toxicity and chemical uses. PABA based Thiazolidinones MS1-MS6 was synthesized according to reported methods. The structural features of the synthesized compounds were investigated using spectral as well as DFT tools. Various parameters such as HOMO/LUMO energy gaps and global chemical properties were computed with DFT. Thiazolidinones MS1-MS6 were screened to evaluate their in vitro enzyme inhibition potential. In-Silico ADMET and docking studies were performed to check the therapeutic properties of thiazolidinone derivatives. The highest activity was depicted by MS4 with a percentage inhibition of 81.7 ± 1.1% against AChE which was further elaborated with molecular dynamic simulation. Both experimental and theoretical assessments suggested the therapeutic importance of the thiazolidinone derivatives. [ABSTRACT FROM AUTHOR]
Additional Information
- Source:Journal of Computational Biophysics & Chemistry. 2024/10, Vol. 23, Issue 8, p1011
- Document Type:Article
- Subject Area:Health and Medicine
- Publication Date:2024
- ISSN:2737-4165
- DOI:10.1142/S273741652450025X
- Accession Number:179710515
- Copyright Statement:Copyright of Journal of Computational Biophysics & Chemistry is the property of World Scientific Publishing Company and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Looking to go deeper into this topic? Look for more articles on EBSCOhost.